Results 11 to 20 of about 28,077 (207)

Interpretation and Elaboration for the ARRIVE Guidelines 2.0—Animal Research: Reporting In Vivo Experiments (V)

open access: yesShiyan dongwu yu bijiao yixue
Improving the reproducibility of biomedical research results is a major challenge. Transparent and accurate reporting of the research process enables readers to evaluate the reliability of the research results and further explore the experiment by ...
MA Zhengwen   +12 more
doaj   +3 more sources

Resveratrol and Curcumin for Chagas Disease Treatment—A Systematic Review

open access: yesPharmaceuticals, 2022
Chagas disease (CD) is a neglected protozoan infection caused by Trypanosoma cruzi, which affects about 7 million people worldwide. There are two available drugs in therapeutics, however, they lack effectiveness for the chronic stage—characterized mainly
Carlos Henrique Lima Imperador   +8 more
doaj   +2 more sources

Guideline Checklist for Publishing Research Papers on Animal Experimentation and Comparative Medicine in China (2024 Edition)

open access: yesShiyan dongwu yu bijiao yixue
The standardization, transparency, and completeness of research papers in animal experimentation and comparative medicine research are crucial for ensuring the credibility, reproducibility, and clinical applicability of research findings. Internationally
Editorial Board of Laboratory Animal and Comparative Medicine
doaj   +2 more sources

Reporting Practices for Animal Studies on Peritoneal Dialysis Conducted in 2021-2023 after the Introduction of the ARRIVE 2.0 Guidelines.

open access: yesNephron
<b><i>Introduction:</i></b> The first version of Animal Research: Reporting of in vivo Experiments (ARRIVE 1.0) guidelines was introduced to improve reporting of animal research but did not lead to major improvements in this respect. This applied also to animal studies on peritoneal dialysis (PD).
Witowski J, Sikorska D, Catar R.
europepmc   +3 more sources

In vivo toxicity of chitosan-based nanoparticles: a systematic review

open access: yesArtificial Cells, Nanomedicine, and Biotechnology
Chitosan nanoparticles have been extensively utilised as polymeric drug carriers in nanoparticles formulations due to their potential to enhance drug delivery, efficacy, and safety.
Shela Salsabila   +6 more
doaj   +2 more sources

ARRIVE 2.0 guidelines

open access: yes
Arrive ...
Sree Lalitha Bojja (17524593)
openaire   +2 more sources

Preclinical models of maternal asthma and progeny outcomes: a scoping review

open access: yesEuropean Respiratory Review
There is an increased risk of adverse perinatal outcomes in the ∼17% of women with asthma during pregnancy. The mechanisms linking maternal asthma and adverse outcomes are largely unknown, but reflect joint effects of genetics and prenatal exposure to ...
Joshua L. Robinson   +6 more
doaj   +2 more sources

CRIME-Q—a unifying tool for critical appraisal of methodological (technical) quality, quality of reporting and risk of bias in animal research [PDF]

open access: yesBMC Medical Research Methodology
Background Systematic reviews within the field of animal research are becoming more common. However, in animal translational research, issues related to methodological quality and quality of reporting continue to arise, potentially leading to ...
Mikkel Schou Andersen   +8 more
doaj   +2 more sources

Explanation and Elaboration of the ARRIVE Guidelines 2.0—Reporting Animal Research and In Vivo Experiments (Ⅱ)

open access: yesShiyan dongwu yu bijiao yixue, 2023
Improving the reproducibility of biomedical research results remains a major challenge. Transparent and accurate reporting of progress can help readers evaluate the reliability of research results and further explore an experiment by repeating or ...
CHEN Guoyuan   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy